ProMetic Life Sciences Inc. (TSX:PLI) (“ProMetic”) is pleased to confirm the closing of its financing as announced on September 4, 2007, for gross proceeds of C$6,609,375. ProMetic issued 18,883,928 subordinate voting shares (“Subordinate Shares”) at a price of C$0.35 per Subordinate Share.
